ArticleJournal of palliative medicine2019
How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.
Article in Journal of palliative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- Key challenges in communication across milestones of cancer care continuum: a systematic review.BMC palliative care · 2026Pooled it
- Improving communication of prognostic uncertainty in advanced illness: a realist review.BMJ open · 2026Pooled it
- Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.Blood advances · 2026Trial
- Article
- More than "hematology": a qualitative study on the experience of hematologists treating people with blood cancer in Greece.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- A cross-sectional survey on health care professionals' approaches, challenges, and support needs when addressing life threat with recipients of an allogeneic hematopoietic stem cell transplantation and with their relatives.Annals of hematology · 2025Article
- Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians.Annals of hematology · 2024Article
- Perspectives of Patients With Relapsed and Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome on Patient-Clinician Communication About Prognosis and the Future.Palliative medicine reports · 2024Article
- Silent Conversations: Goals of Care and End-of-Life Quality in Relapsed High-Risk Leukemia.Journal of the advanced practitioner in oncology · 2023Article
- Differential Impact of a Multicomponent Goals-of-Care Program in Patients with Hematologic and Solid Malignancies.Cancers · 2023Article
- Development and Evaluation of a Decision Aid to Support Patients' Participatory Decision-Making for Tumor-Specific and Palliative Therapy for Advanced Cancer: Protocol for a Pre-Post Study.JMIR research protocols · 2021Article
- Prevalence and Tolerance of Prognostic Uncertainty Among Thoracic Oncologists.The oncologist · 2021Article
- Discussing Prognosis with Empathy to Cancer Patients.Current oncology reports · 2021Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.